New cell-based therapy for melanoma more effective than existing treatment, trial finds

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 53 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 86%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

European researchers have found a new treatment for advanced melanoma that is more effective than the leading existing therapy.

And while it’s been explored for solid tumors, which make up the majority of cancers, including melanoma, these tumors present challenges that blood cancers do not. Many blood cancers are homogeneous, meaning their cells are uniform. This gives CAR-T therapy a clear target to latch onto and attack. But solid tumors tend to have a number of different cell types that vary largely between cancer types, said Dr.

“We expand them from a million cells to several billion cells,” Dr. John Haanen, a medical oncologist at the Netherlands Cancer Institute, who led the new clinical trial, told NBC News. In the trial, 168 patients with metastatic melanoma were randomly assigned to receive either TIL treatment or the current standard treatment, ancalled ipilimumab. Ipilimumab is typically used in people who don’t respond to a first-line treatment called anti-PD-1 therapy; nearly all of the patients in the trial had not responded to that treatment.

“It’s the first time that we’ve had a result like that with a cell therapy immunotherapy for patients with melanoma,” said Davies, who is on the scientific advisory board for Iovance Biotherapeutics, a California-based company that is conducting aMelanoma rates have been rising rapidly in the United States over the past 30 years, and although metastatic melanoma, the most serious stage of the disease, in which the cancer has spread to other parts of the body, is relatively rare, it’s often...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Now if only America could catch up with the latest treatments it would be a blessing

W

That’s a great

CHINA TARGETED AMERICA WITH FENTANYL - NUMBER 1 KILLER OF AMERICANS FROM AGES 18 TO 45 -- CHINA TARGETED NATO & NATIONS WITH NUCLEAR WEAPONS 'PROGRAMS' HAD 98% OF ALL COVID CASES - CHINA 'NO 1ST WAVE' OUTSIDE OF WUHAN - INOCULATED ITS POPULATION PRE-PANDEMIC EXCEPT PART OF WUHAN

Modifying T-cells. What can go wrong?

🔥✔️

Well unlike US greedy disgusting companies I'm sure they'll charge a reasonable price for their medicine unlike the US who wants to charge $30 000 a pill

Is this a conspiracy too or is it only the people who make vaccines that are faking it?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 10. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study Finds LSD Therapy Strikingly Effective at Reducing Anxiety and DepressionAccording to new research, LSD-assisted therapy could be a surprisingly effective and long-lasting treatment for anxiety and depression-related symptoms. Pretty interesting. I can give my testimony that Magic shrooms are amazing. I had shroom caps and shroom chocolate bars before and had great experience with them. Totally fix my depression and anxiety. It definitely changes your perspective in mind, body, and soul. It’s Nirvana.
Source: futurism - 🏆 85. / 68 Read more »

PANTHER: Should Clopidogrel Become the 'New Aspirin' in CAD?The PANTHER meta-analysis of trials comparing aspirin with clopidogrel or ticagrelor as antiplatelet monotherapy in coronary artery disease patients suggest that P2Y12 inhibitor therapy is more effective.
Source: Medscape - 🏆 386. / 55 Read more »

Scientists attempt to beat cancer by suffocating cells within four hoursThe new treatment hold great promise for normally unbeatable types of cancer.
Source: IntEngineering - 🏆 287. / 63 Read more »

Precision medicine improves outcomes in metastatic breast cancerA randomized phase II clinical trial reveals that using genomic analyses to target therapy improves progression-free survival in people with breast cancers that have spread.
Source: Nature - 🏆 64. / 68 Read more »